๐
๐๐ฌ๐ญ๐๐ฌ๐ญ ๐๐ซ๐จ๐ฐ๐ข๐ง๐ ๐๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ!
I previously wrote about the revenue of some of the top #medicaldevice companies over the past 15 years. On average the #revenue growth of these companies has been roughly 60% (compound annual growth rate of 4%). But the revenue #growth has not been the same for all these companies.
The following are some of the fastest-growing medical device companies by revenue
1.ย ย ย ย ย Stryker
2.ย ย ย ย ย BD
3.ย ย ย ย ย Medtronic
4.ย ย ย ย ย Fresenius Medical Care
5.ย ย ย ย ย Siemens Healthineers
6.ย ย ย ย ย Boston Scientific
ย
Time will tell if these companies can maintain their #momentum.
ย
๐๐ข๐ฆ๐ข๐ญ๐๐ญ๐ข๐จ๐ง๐ฌ ๐จ๐ ๐ซ๐๐ฏ๐๐ง๐ฎ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
Top-line growth is one of the key factors when it comes to the evaluation of the financial strength of a business, but it also has its own limitations. Revenue growth alone does not fully represent the company's performance, as it benefits from #acquisitions and suffers from #divestitures.
For the companies that are listed here, in some cases, the revenue growth has been organic while in other cases it has been achieved through major acquisitions. Acquisitions of #Varian by Siemens Healthineers for $16B, #Covidien by Medtronic for $43B, #Bard by BD for $24B, and #Sage, #WrightMedical, and #Vocera by Stryker for a total of $10B are all good examples of this. Additionally, some of these companies have strategically divested some of their businesses. GE Healthcare selling its #BioPharma to Danaher for $21B, and Philips divesting its Lighting and most of its #ConsumerLifestyle are all good examples of this.
To gain a deeper understanding of each of these companies, one must dive into their strategy, business model, product portfolio, global operations, and overall financial and economics.
Sources: MacroTrends, Google Finance, individual company financials
* For European companies like Philips and Siemens I used their revenue growth in Euros and avoided conversion to USD.
* For Philips I excluded the revenue from their lighting division and only included the revenue from Healthcare & Consumer Lifestyle. Philips divested 80% of its Consumer Lifestyle over the years.
* Views and ideas are my own. The content that I provide here is intended to be educational only and is not financial advice. I have personal investments in several public and private tech and medtech companies, but always encourage the readers to do their research.
I previously wrote about the revenue of some of the top #medicaldevice companies over the past 15 years. On average the #revenue growth of these companies has been roughly 60% (compound annual growth rate of 4%). But the revenue #growth has not been the same for all these companies.
The following are some of the fastest-growing medical device companies by revenue
1.ย ย ย ย ย Stryker
2.ย ย ย ย ย BD
3.ย ย ย ย ย Medtronic
4.ย ย ย ย ย Fresenius Medical Care
5.ย ย ย ย ย Siemens Healthineers
6.ย ย ย ย ย Boston Scientific
ย
Time will tell if these companies can maintain their #momentum.
ย
๐๐ข๐ฆ๐ข๐ญ๐๐ญ๐ข๐จ๐ง๐ฌ ๐จ๐ ๐ซ๐๐ฏ๐๐ง๐ฎ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
Top-line growth is one of the key factors when it comes to the evaluation of the financial strength of a business, but it also has its own limitations. Revenue growth alone does not fully represent the company's performance, as it benefits from #acquisitions and suffers from #divestitures.
For the companies that are listed here, in some cases, the revenue growth has been organic while in other cases it has been achieved through major acquisitions. Acquisitions of #Varian by Siemens Healthineers for $16B, #Covidien by Medtronic for $43B, #Bard by BD for $24B, and #Sage, #WrightMedical, and #Vocera by Stryker for a total of $10B are all good examples of this. Additionally, some of these companies have strategically divested some of their businesses. GE Healthcare selling its #BioPharma to Danaher for $21B, and Philips divesting its Lighting and most of its #ConsumerLifestyle are all good examples of this.
To gain a deeper understanding of each of these companies, one must dive into their strategy, business model, product portfolio, global operations, and overall financial and economics.
Sources: MacroTrends, Google Finance, individual company financials
* For European companies like Philips and Siemens I used their revenue growth in Euros and avoided conversion to USD.
* For Philips I excluded the revenue from their lighting division and only included the revenue from Healthcare & Consumer Lifestyle. Philips divested 80% of its Consumer Lifestyle over the years.
* Views and ideas are my own. The content that I provide here is intended to be educational only and is not financial advice. I have personal investments in several public and private tech and medtech companies, but always encourage the readers to do their research.